MIZUHO MEDY CO.,LTD. (4595.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

10.3x

EV/EBITDA

4.4x

Market Cap

JPY 32.67B

MomentumView details →

1D Return

−0.46%

YTD Return

+0.35%

RSI (14)

50.2

ValuationView details →

P/E (Fwd)

10.3x

EV/EBITDA

4.4x

Market Cap

JPY 32.67B

RSI (14)

50.2

MomentumView details →

1D Return

−0.46%

YTD Return

+0.35%

ProfitabilityView details →

Gross Margin

72.27%

Net Margin

30.03%

EBITDA Margin

45.40%

ROE (TTM)

17.72%

ROA (TTM)

15.52%

Asset Turnover

0.50x

GrowthView details →

Revenue YoY

−4.56%

EPS YoY

−9.25%

FCF YoY

—

Revenue CAGR 3Y

−13.80%

EPS CAGR 3Y

−39.77%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

11.59x

Quick Ratio

10.78x

Div Yield

2.92%

Div Rate

JPY 100.00

Div Growth 1Y

−50.00%

Financials snapshotView financials →

Revenue (TTM)

10.82B

Net Income (TTM)

3.25B

Op. CF (TTM)

—

Next earningsNov 6, 2026 →

Latest newsMore news →

Mizuho Medy announced its financial results for the first half of fiscal year ending December 2026, with recurring profit down 20.5% year-on-year to 1.11 billion yen, and second-quarter (April-June) recurring profit down 13.5% to 280 million yen.24d ago

Mizuho Medy announced it will launch the Smart Gene Pertussis nucleic acid kit on August 3, 2026.50d ago

Similar companies

HEALIOS K.K.4593.T SEIKAGAKU CORPORATION4548.T Daito Pharmaceutical Co.,Ltd.4577.T Innovacell Inc.504A.T Fuji Pharma Co.,Ltd.4554.T Cuorips Inc.4894.T Find similar companies →

Latest newsMore news →

Mizuho Medy announced its financial results for the first half of fiscal year ending December 2026, with recurring profit down 20.5% year-on-year to 1.11 billion yen, and second-quarter (April-June) recurring profit down 13.5% to 280 million yen.24d ago Mizuho Medy announced it will launch the Smart Gene Pertussis nucleic acid kit on August 3, 2026.50d ago